Emad Hasan
Duke University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Emad Hasan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:45 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07493577 · Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2)Dr David Hasan, M.D. · not yet recruiting · Aneurysmal Subarachnoid Hemorrhage · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Induced Suppression of Platelet Activity in Aneurysmal SAH Management-2 (iSPASM-2)UG3NS138219 · NINDS · DUKE UNIVERSITY · PI Spiros Blackburn, David M Hasan, Brian Mac Grory · fiscal years 2025Named on NCT07493577
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:45 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- 14 citationsRCR 0.4
- Efficacy of Sofosbuvir plus Ledipasvir in Egyptian patients with COVID-19 compared to standard treatment: a randomized controlled trial.J Med Life · 202213 citationsRCR 0.8
- Trace-level determination of nifedipine in human serum by reversed phase high performance liquid chromatography.Pol J Pharmacol · 20004 citationsRCR 0.3
- 1 citationsRCR 0.1